cabergoline has been researched along with buserelin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gabai, G; Marinelli, L; Mollo, A; Rota, A; Vincenti, L | 1 |
| Čehić, E; Franulić, D; Grgić, F; Kasum, M; Lila, A; Orešković, S; Vujić, G | 1 |
| Balayla, J; Dahan, MH; Shrem, G; Son, WY; Steiner, N; Tannus, S; Volodarsky-Perel, A | 1 |
1 review(s) available for cabergoline and buserelin
| Article | Year |
|---|---|
Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome
Topics: Aminoquinolines; Bromocriptine; Buserelin; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Ergolines; Estradiol; Estrogens; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone; Progestins; Triptorelin Pamoate | 2017 |
1 trial(s) available for cabergoline and buserelin
| Article | Year |
|---|---|
Evaluation of cabergoline and buserelin efficacy for oestrous induction in the bitch.
Topics: Administration, Oral; Animals; Buserelin; Cabergoline; Dogs; Drug Administration Schedule; Ergolines; Estrus; Female; Fertility Agents, Female; Injections, Subcutaneous; Pregnancy; Prolactin; Treatment Outcome | 2003 |
1 other study(ies) available for cabergoline and buserelin
| Article | Year |
|---|---|
Use of cabergoline and post-collection GnRH antagonist administration for prevention of ovarian hyperstimulation syndrome.
Topics: Adult; Buserelin; Cabergoline; Dopamine Agonists; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Retrospective Studies | 2019 |